Na Xie

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 19

Top Topics

Body Composition

Bone Mineral Density

Loop Mediated Isothermal Amplification

Postmenopausal Women

Top Venues

Signal transduction and targeted therapy

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Yuan-Yuan Zhang, Na Xie, Xiao-Dong Sun, Edouard C Nice, Yih-Cherng Liou, Canhua Huang, Huili Zhu, Zhisen Shen
Author Correction: Insights and implications of sexual dimorphism in osteoporosis. Bone research 12 (1) (2024)
Yuan-Yuan Zhang, Na Xie, Xiao-Dong Sun, Edouard C Nice, Yih-Cherng Liou, Canhua Huang, Huili Zhu, Zhisen Shen
Author Correction: Insights and implications of sexual dimorphism in osteoporosis. Bone research 12 (1) (2024)
Yuan-Yuan Zhang, Na Xie, Xiao-Dong Sun, Edouard C Nice, Yih-Cherng Liou, Canhua Huang, Huili Zhu, Zhisen Shen
Insights and implications of sexual dimorphism in osteoporosis. Bone research 12 (1) (2024)
Yuan-Yuan Zhang, Na Xie, Xiao-Dong Sun, Edouard C Nice, Yih-Cherng Liou, Canhua Huang, Huili Zhu, Zhisen Shen
Insights and implications of sexual dimorphism in osteoporosis. Bone research 12 (1) (2024)
Yuan-Yuan Zhang, Na Xie, Xiao-Dong Sun, Edouard C Nice, Yih-Cherng Liou, Canhua Huang, Huili Zhu, Zhisen Shen
Insights and implications of sexual dimorphism in osteoporosis. Bone research 12 (1) (2024)
Zizhuo Xie, Yuan Tian, Xiaohan Guo, Na Xie
The emerging role of CARM1 in cancer. Cellular oncology (Dordrecht) (2024)
Yujing Huang, Xiaohan Guo, Yi Wu, Xingyu Chen, Lixiang Feng, Na Xie, Guobo Shen
Nanotechnology's frontier in combatting infectious and inflammatory diseases: prevention and treatment. Signal transduction and targeted therapy 9 (1) (2024)
Yuan-Yuan Zhang, Na Xie, Xiao-Dong Sun, Edouard C Nice, Yih-Cherng Liou, Canhua Huang, Huili Zhu, Zhisen Shen
Insights and implications of sexual dimorphism in osteoporosis. Bone research 12 (1) (2024)
Yujing Huang, Xiaohan Guo, Yi Wu, Xingyu Chen, Lixiang Feng, Na Xie, Guobo Shen
Nanotechnology's frontier in combatting infectious and inflammatory diseases: prevention and treatment. Signal transduction and targeted therapy 9 (1) (2024)
Xin Zheng, Tao Gong, Wanyi Luo, Bing Hu, Jinhang Gao, Yuqing Li, Rui Liu, Na Xie, Wenming Yang, Xin Xu, Lei Cheng, Chenchen Zhou, Quan Yuan, Canhua Huang, Xian Peng, Xuedong Zhou
Fusobacterium nucleatum extracellular vesicles are enriched in colorectal cancer and facilitate bacterial adhesion. Science advances 10 (38) (2024)
Yuan-Yuan Zhang, Na Xie, Xiao-Dong Sun, Edouard C Nice, Yih-Cherng Liou, Canhua Huang, Huili Zhu, Zhisen Shen
Author Correction: Insights and implications of sexual dimorphism in osteoporosis. Bone research 12 (1) (2024)
Yujing Huang, Xiaohan Guo, Yi Wu, Xingyu Chen, Lixiang Feng, Na Xie, Guobo Shen
Nanotechnology's frontier in combatting infectious and inflammatory diseases: prevention and treatment. Signal transduction and targeted therapy 9 (1) (2024)
Yujing Huang, Xiaohan Guo, Yi Wu, Xingyu Chen, Lixiang Feng, Na Xie, Guobo Shen
Nanotechnology's frontier in combatting infectious and inflammatory diseases: prevention and treatment. Signal transduction and targeted therapy 9 (1) (2024)
Yuan-Yuan Zhang, Na Xie, Xiao-Dong Sun, Edouard C Nice, Yih-Cherng Liou, Canhua Huang, Huili Zhu, Zhisen Shen
Insights and implications of sexual dimorphism in osteoporosis. Bone research 12 (1) (2024)
Yuan-Yuan Zhang, Na Xie, Xiao-Dong Sun, Edouard C Nice, Yih-Cherng Liou, Canhua Huang, Huili Zhu, Zhisen Shen
Insights and implications of sexual dimorphism in osteoporosis. Bone research 12 (1) (2024)
Peijie Wu, Jun Han, Yanju Gong, Chao Liu, Han Yu, Na Xie
Nanoparticle-Based Drug Delivery Systems Targeting Tumor Microenvironment for Cancer Immunotherapy Resistance: Current Advances and Applications. Pharmaceutics 14 (10) (2022)
Xingyu Chen, Lixiang Feng, Yujing Huang, Yi Wu, Na Xie
Mechanisms and Strategies to Overcome PD-1/PD-L1 Blockade Resistance in Triple-Negative Breast Cancer. Cancers 15 (1) (2022)
Xingyu Chen, Lixiang Feng, Yujing Huang, Yi Wu, Na Xie
Mechanisms and Strategies to Overcome PD-1/PD-L1 Blockade Resistance in Triple-Negative Breast Cancer. Cancers 15 (1) (2022)
Xingyu Chen, Lixiang Feng, Yujing Huang, Yi Wu, Na Xie
Mechanisms and Strategies to Overcome PD-1/PD-L1 Blockade Resistance in Triple-Negative Breast Cancer. Cancers 15 (1) (2022)